The DOI matches its Crossref record; 768 of the 768 references it cites were found in a registry or an index.
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Open accessAbstract
Artificial intelligence (AI), and, in particular, deep learning as a subcategory of AI, provides opportunities for the discovery and development of innovative drugs. Various machine learning approaches have recently (re)emerged, some of which may be considered instances of domain-specific AI which have been successfully employed for drug discovery and design. This review provides a comprehensive portrayal of these machine learning techniques and of their applications in medicinal chemistry. After introducing the basic principles, alongside some application notes, of the various machine learning algorithms, the current state-of-the art of AI-assisted pharmaceutical discovery is discussed, including applications in structure- and ligand-based virtual screening, de novo drug design, physicochemical and pharmacokinetic property prediction, drug repurposing, and related aspects. Finally, several challenges and limitations of the current methods are summarized, with a view to potential future directions for AI-assisted drug discovery and design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deep Residual Learning for Image Recognition
He, K., Zhang, X., Ren, S., & Sun, J. (2016) · 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2016.90 · Cited by 235,474
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
Maximum Likelihood from Incomplete Data Via the EM Algorithm
Dempster, A. P., Laird, N. M., & Rubin, D. B. (1977) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1977.tb01600.x · Cited by 50,444
Densely Connected Convolutional Networks
Huang, G., Liu, Z., Van Der Maaten, L., & Weinberger, K. Q. (2017) · 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2017.243 · Cited by 48,566
(2014) · Cited by 33,419
(2008) · Journal of Machine Learning Research · Cited by 33,051
SMOTE synthetic minority over-sampling technique
Chawla, N. V., Bowyer, K. W., Hall, L. O., & Kegelmeyer, W. P. (2002) · Journal of Artificial Intelligence Research · doi:10.1613/jair.953 · Cited by 32,865
Cited by
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“They also intend to establish a uniform data format, which is technically challenging [161].”
BackgroundMethodComputational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
The role of artificial intelligence in healthcare: a structured literature review
Secinaro, S., Calandra, D., Secinaro, A., Muthurangu, V., & Biancone, P. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01488-9 · Cited by 1,085
Drug discovery with explainable artificial intelligence
Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063
Self-citationRethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Self-citationLoh, H. W., Ooi, C. P., Seoni, S., Barua, P. D., Molinari, F., & Acharya, U. R. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.107161 · Cited by 734
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Sun, S., Shen, J., Jiang, J., Wang, F., & Min, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01606-1 · Cited by 608
Artificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 498
Self-citationArtificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Self-citationVatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Machine Learning for Electronically Excited States of Molecules
Westermayr, J., & Marquetand, P. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00749 · Cited by 398
Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR
Tropsha, A., Isayev, O., Varnek, A., Schneider, G., & Cherkasov, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00832-0 · Cited by 397
Self-citationTransfer Learning for Drug Discovery
Cai, C., Wang, S., Xu, Y., Zhang, W., Tang, K., Ouyang, Q., Lai, L., & Pei, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02147 · Cited by 366
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Deng, L.-J., Deng, W.-Q., Fan, S.-R., Chen, M.-F., Qi, M., Lyu, W.-Y., Qi, Q., Tiwari, A. K., Chen, J.-X., Zhang, D.-M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01510-2 · Cited by 366
Advances in De Novo Drug Design: From Conventional to Machine Learning Methods
Mouchlis, V. D., Afantitis, A., Serra, A., Fratello, M., Papadiamantis, A. G., Aidinis, V., Lynch, I., Greco, D., & Melagraki, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041676 · Cited by 353
Xie, C., Zhuang, X.-X., Niu, Z., Ai, R., Lautrup, S., Zheng, S., Jiang, Y., Han, R., Gupta, T. S., Cao, S., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00819-5 · Cited by 336
Discovering Anti-Cancer Drugs via Computational Methods
Cui, W., Aouidate, A., Wang, S., Yu, Q., Li, Y., & Yuan, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00733 · Cited by 307
Multifunctional hydrogel as wound dressing for intelligent wound monitoring
Wang, L., Zhou, M., Xu, T., & Zhang, X. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134625 · Cited by 306
Bai, Q., Tan, S., Xu, T., Liu, H., Huang, J., & Yao, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa161 · Cited by 287
Visan, A. I., & Negut, I. (2024) · Life · doi:10.3390/life14020233 · Cited by 279
A review of large language models and autonomous agents in chemistry
Ramos, M. C., Collison, C. J., & White, A. D. (2025) · Chemical Science · doi:10.1039/d4sc03921a · Cited by 274
Wang, Z., Afgan, M. S., Gu, W., Song, Y., Wang, Y., Hou, Z., Song, W., & Li, Z. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116385 · Cited by 271
Self-citationMolecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed, M. T., & Aki-Yalcin, E. (2024) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220922103109 · Cited by 267
Jiang, D., Hsieh, C.-Y., Wu, Z., Kang, Y., Wang, J., Wang, E., Liao, B., Shen, C., Xu, L., Wu, J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01830 · Cited by 262
LIT-PCBA: An Unbiased Data Set for Machine Learning and Virtual Screening
Tran-Nguyen, V.-K., Jacquemard, C., & Rognan, D. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00155 · Cited by 259
Artificial Intelligence in Pharmaceutical and Healthcare Research
Bhattamisra, S. K., Banerjee, P., Gupta, P., Mayuren, J., Patra, S., & Candasamy, M. (2023) · Big Data and Cognitive Computing · doi:10.3390/bdcc7010010 · Cited by 257
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
Ivanenkov, Y. A., Polykovskiy, D., Bezrukov, D., Zagribelnyy, B., Aladinskiy, V., Kamya, P., Aliper, A., Ren, F., & Zhavoronkov, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01191 · Cited by 231
Generative molecular design in low data regimes
Moret, M., Friedrich, L., Grisoni, F., Merk, D., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0160-y · Cited by 219
Self-citationA critical overview of computational approaches employed for COVID-19 drug discovery
Muratov, E. N., Amaro, R., Andrade, C. H., Brown, N., Ekins, S., Fourches, D., Isayev, O., Kozakov, D., Medina-Franco, J. L., Merz, K. M., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01065k · Cited by 206
Self-citationHe, S., Leanse, L. G., & Feng, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113922 · Cited by 141
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, K., Tang, J., & Vähä-Koskela, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa003 · Cited by 131
Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine
Lin, Y., Zhang, Y., Wang, D., Yang, B., & Shen, Y.-Q. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154481 · Cited by 107
Fu, L., Jin, W., Zhang, J., Zhu, L., Lu, J., Zhen, Y., Zhang, L., Ouyang, L., Liu, B., & Yu, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.006 · Cited by 83
The machine learning life cycle and the cloud: implications for drug discovery
Spjuth, O., Frid, J., & Hellander, A. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1932812 · Cited by 67
Kalasin, S., Sangnuang, P., & Surareungchai, W. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01459 · Cited by 57
Dhamodharan, G., & Mohan, C. G. (2022) · Molecular Diversity · doi:10.1007/s11030-021-10282-8 · Cited by 56
Harnessing systematic protein–ligand interaction fingerprints for drug discovery
Zhao, Z., & Bourne, P. E. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.07.004 · Cited by 41
Adding Stochastic Negative Examples into Machine Learning Improves Molecular Bioactivity Prediction
Cáceres, E. L., Mew, N. C., & Keiser, M. J. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00565 · Cited by 33
Engineering brain-derived neurotrophic factor mRNA delivery for the treatment of Alzheimer’s disease
Li, H., Cao, Y., Ye, J., Yang, Z., Chen, Q., Liu, X., Zhang, B., Qiao, J., Tang, Q., Yang, H., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.143152 · Cited by 32
Mikami, K. (2020) · Polymer · doi:10.1016/j.polymer.2020.122738 · Cited by 22
Fighting COVID-19 with Artificial Intelligence
Monteleone, S., Kellici, T. F., Southey, M., Bodkin, M. J., & Heifetz, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_3 · Cited by 17
Wang, X., Liu, M., Zhang, Y., He, S., Qin, C., Li, Y., & Lu, T. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab289 · Cited by 16
AABBA Graph Kernel: Atom-Atom, Bond-Bond, and Bond-Atom Autocorrelations for Machine Learning
Morán-González, L., Betten, J. E., Kneiding, H., & Balcells, D. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01583 · Cited by 12
Action mechanism of a novel agrichemical quinofumelin against Fusarium graminearum
Xiu, Q., Yin, X., Chen, Y., Zhang, Z., Mao, Y., Wang, T., Zhang, J., Zhou, M., & Duan, Y. (2025) · eLife · doi:10.7554/elife.105892.3 · Cited by 11
Action mechanism of a novel agrichemical quinofumelin against Fusarium graminearum
Xiu, Q., Yin, X., Chen, Y., Zhang, Z., Mao, Y., Wang, T., Zhang, J., Zhou, M., & Duan, Y. (2025) · eLife · doi:10.7554/elife.105892 · Cited by 1
Metadata
- Authors
- Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-07-11
- Volume
- 119
- Issue
- 18
- Pages
- 10520-10594
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2959938226
- Cited by
- 1,022
- References
- 768
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.